Navigation Links
CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting
Date:5/22/2008

ity if early interventions are not successful. Improved pharmacology, as these cases demonstrate, could decrease the high morbidity and mortality in patients with disordered eating."

Primary outcome measures of the study included the 21-item Hamilton Rating for Depression Scale (HDRS) and the Clinical Global Improvement Scale (CGI) and the Clinical Global Severity Scale (SGS). Some of the criteria used to assess improvement in the CGI included: body dissatisfaction, drive for thinness, compulsive exercising, binging and purging.

Improvements in both HDRS and CGI scores were evident at 8-weeks, 6-months, and 2 years (for 4 patients). The medications selected from rEEG correlations involved combinations from many different classes of medications. Stimulant medications in four Eating Disorder patients did not result in appetite suppression or weight loss. These results are consistent with recent findings that ADHD can predict eating disorder pathology in adolescent girls.

The full poster presentation and analysis of results are available via http://www.cnsresponse.com/uploads/assets/0000/0066/rEEGEDPosterCNSR2008.pd f

Greenblatt continued, "Specific patient progress during the study demonstrated the ability of rEEG to have a real impact on the lives of those with severe mental conditions. One anorexia nervosa patient had previously received five different medication regimes, none of which provided any improvement. The patient had been hospitalized on five separate occasions during the two years prior to rEEG testing. Based on the rEEG report, we medicated the patient with a combination of Oxcarbazepine and Duloxetine. This treatment combination is outside of the traditional medications we would have considered. In fact, there are no medications that have shown consistent success in treatment of anorexia nervosa. For the 24 months following
'/>"/>

SOURCE CNS Response, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohns Disease
2. Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients
3. Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
4. New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
5. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
6. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
7. Gene Therapy Provides Vision to People who Were Nearly Blind
8. Arpida Provides Further Comments on the Pivotal Phase III Trials
9. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
10. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
11. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 China,s ... earthshaking changes. The country,s new leaders have recognized that ... reagents are far from perfect along with rapid population ... Chinese state council issued the latest "Regulations for the ... 2014, and it has come into force as June ...
(Date:9/29/2014)... and PARIS , Sept. 30, 2014 ... (EURONEXT: SAN and NYSE: SNY) today announced that a ... that blocks IL-4 and IL-13 signaling, met all primary ... with nasal polyps (CSwNP) who did not respond to ... potential of dupilumab for use in the treatment of ...
(Date:9/29/2014)... DUBLIN , Sept. 29, 2014  TNI ... biotechnology company pioneering the manufacturing both US and Internationally ... cancer, HIV/AIDS, opportunistic infections and autoimmune diseases in emerging ... Noreen Griffin The letter follows: Dear Shareholders, ... received a number of calls from shareholders and wants ...
Breaking Medicine Technology:Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 5Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 2Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 3Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 4Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 5Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 6Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 7TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 2TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 3TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 4TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 5TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 6TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 7TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 8
... 9, 2011 The "Scientific Oktoberfest" will be ... distinguished researchers in the field of Chemical Biology. The so-called ... from the 15 th to the 16 th ... (LMU) München. At the two-day conference, 400 researchers ...
... Holdings, Inc., (NYSE: HRC ) today announced ... Item SA and Liko Care AG, the distribution companies ... Switzerland.  Hill-Rom, the global leader in patient support solutions, ... acquisition of Liko, A.B., a leading provider of patient ...
Cached Medicine Technology:"Scientific Oktoberfest" Draws the Worldwide Leading Researchers in the Field of Chemical Biology to Munich 2Hill-Rom Acquires Liko France and Switzerland 2Hill-Rom Acquires Liko France and Switzerland 3
(Date:9/30/2014)... IL (PRWEB) September 30, 2014 From ... will be exhibiting at the 2014 SHSMD Connections Annual ... Society for Healthcare Strategy & Market Development (SHSMD) is ... healthcare marketing, public relations and communications, and strategic planning ... , About SHSMD Connections , The conference is a ...
(Date:9/30/2014)... placebo did not reduce hospital length of stay, intensive ... the risk of death at 6 months among patients ... to a study published in JAMA . The ... its presentation at the European Society of Intensive Care ... low vitamin D levels has been confirmed in patients ...
(Date:9/30/2014)... New Albany, IN (PRWEB) September 30, 2014 ... Dr. Ron Receveur encourages all persons who have ... gum disease in a recent blog post. , The ... reminds those with dental implants that if they don’t ... in the same way people lose their natural teeth: ...
(Date:9/30/2014)... 2014 Youth Town’s annual BBQ/Music Festival ... to 2 p.m. at the Youth Town campus (3641 ... sponsors this family-oriented festival, which will offer music, food ... feature a car show, arts and crafts fair, music, ... games. Also, Lightning McQueen and Mater from the hit ...
(Date:9/30/2014)... September 30, 2014 “Biology and ... Bryan W. Brickner, “and it’s about naming rights.” ... Science , new on the Bryan William Brickner ... the National Institutes of Health (PubMed). The post ... sleep disturbances, REM transitions, aging with THC, the ...
Breaking Medicine News(10 mins):Health News:MMS, Inc. (Medical Marketing Service) to Attend the 2014 SHSMD Connections Annual Conference in October 2Health News:High-dose vitamin D for ICU patients who are vitamin D deficient does not improve outcomes 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 3Health News:Homeostasis: Publius’ Sleep Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2
... to have their blood sugar, blood pressure, and cholesterol ... a high-quality Medicare plan, researchers reported Tuesday. ... Medical Association, show that racial disparities are common throughout ... Amal N. Trivedi of Brown University in Providence, Rhode ...
... about personalized medicine enabled through genetic testing, slated to ... would not only involve forecasting the presence of a ... but will also enable early prevention strategies. ... cardiovascular diseases, but will unravel the genetic blue prints ...
... of folic acid every day could have better chance of getting ... form of vitamin B is used in our bodies to make ... body before she is pregnant, it can help prevent major birth ... study involving more than 18,000 women for the first time revealed ...
... Regular exercise combined with nicotine replacement therapy could help ... colleagues at the Otto Wagner Hospital// in Vienna enrolled ... nicotine-replacement therapy, reported the online edition of health magazine ... be quitters enrolled in an exercise programme., ,The ...
... to a recent study, women with a twin are at upto ... without one//. ,The study was conducted on over 800 ... premature ovarian failure (POF) at the age of 40 was 3-5 ... causes the ovaries to shut down ten years or earlier than ...
... and toddlers, reports a major study conducted on the side effects ... government proposed immunization for all kids of the age 6 months ... a sharp rise in the number of children getting vaccinated. This ... 2 years as often as the old people. ,This ...
Cached Medicine News:Health News:Medicare Marked by Widespread Racial disparities 2Health News:Folic Acid Supplements Could Help Conception 2
... the new large power line ... function as both cordless AND ... in flexibility. Its the versatility ... with the security of the ...
... is a full-function, electric powered system ... a wide range of surgical applications ... Bone Orthopedics, Orthopedic Trauma, Oral and ... Surgery. Because it is a complete, ...
The 7500 Drill/Reamer operates at two speeds for multiple applications, which is automatically controlled by the 16 different coupler attachments. The drill reamer can be used for, but is not limited...
... Surgical's Breakthrough in Battery Powered Orthopedic Systems., ... revolutionary new addition to the Hall® Surgical ... Battery System is the first and only ... the market. It is a full-function orthopedic ...
Medicine Products: